Showing results (1101-1110 of 1,205) with videos related to
Sort By:
Pageof 121
Journal of Medicinal Chemistry|December 1, 1988
Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonistsB E Evans, K E Rittle, M G Bock, et al.Endocrinology|July 1, 1989
A structurally unique, potent, and selective oxytocin antagonist derived from Streptomyces silvensisD J Pettibone, B V Clineschmidt, P S Anderson, et al.Arthritis Research & Therapy|March 21, 2023
Radiographic airway abnormalities in untreated early rheumatoid arthritis are associated with peripheral neutrophil activationTilia Selldén, Carina Kärrman Mårdh, Martin Joelsson, et al.Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus|August 24, 2018
Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or gastroesophageal junction: long-term results of a randomized clinical trialG A von Döbeln, F Klevebro, A-B Jacobsen, et al.Journal of Medicinal Chemistry|December 10, 1993
Nanomolar-affinity, non-peptide oxytocin receptor antagonistsB E Evans, G F Lundell, K F Gilbert, et al.Journal of Medicinal Chemistry|May 1, 1983
Antihypertensive beta-adrenergic blocking agents: N-aralkyl analogues of 2-[3-(tert-butylamino)-2-hydroxypropoxy]-3-cyanopyridineD E McClure, J J Baldwin, W C Randall, et al.Journal of Medicinal Chemistry|October 16, 1992
Development of a novel class of cyclic hexapeptide oxytocin antagonists based on a natural productP D Williams, M G Bock, R D Tung, et al.Journal of Medicinal Chemistry|July 1, 1987
Design of nonpeptidal ligands for a peptide receptor: cholecystokinin antagonistsB E Evans, K E Rittle, M G Bock, et al.Gut|July 14, 1999
Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classificationL R Lundell, J Dent, J R Bennett, et al.Human Pathology|July 20, 2021
Interobserver agreement of a gastric adenocarcinoma tumor regression grading system that incorporates assessment of lymph nodesAndrianos Tsekrekos, Michael Vieth, Nelson Ndegwa, et al.Pageof 121